Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proton Therapy | 17 | 2023 | 27 | 5.510 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 11 | 2023 | 176 | 2.510 |
Why?
|
| Radiotherapy, Intensity-Modulated | 8 | 2023 | 173 | 2.190 |
Why?
|
| Ependymoma | 2 | 2023 | 17 | 1.030 |
Why?
|
| Protons | 5 | 2023 | 98 | 0.920 |
Why?
|
| Eye | 1 | 2017 | 111 | 0.590 |
Why?
|
| Thoracic Neoplasms | 1 | 2017 | 64 | 0.590 |
Why?
|
| Proprotein Convertase 1 | 4 | 2006 | 11 | 0.570 |
Why?
|
| Protein Precursors | 3 | 2006 | 143 | 0.540 |
Why?
|
| Movement | 2 | 2017 | 299 | 0.540 |
Why?
|
| Algorithms | 4 | 2019 | 1830 | 0.520 |
Why?
|
| Phantoms, Imaging | 5 | 2023 | 429 | 0.490 |
Why?
|
| Organs at Risk | 5 | 2023 | 41 | 0.490 |
Why?
|
| Radiotherapy Dosage | 6 | 2023 | 468 | 0.490 |
Why?
|
| Aspartic Acid Endopeptidases | 3 | 2003 | 66 | 0.480 |
Why?
|
| Radiotherapy, Computer-Assisted | 1 | 2011 | 25 | 0.420 |
Why?
|
| Proinsulin | 2 | 2002 | 124 | 0.420 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2003 | 371 | 0.410 |
Why?
|
| Peptide Fragments | 3 | 2003 | 460 | 0.380 |
Why?
|
| Monte Carlo Method | 3 | 2023 | 185 | 0.380 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 1036 | 0.360 |
Why?
|
| Quality Assurance, Health Care | 2 | 2019 | 220 | 0.320 |
Why?
|
| Breath Holding | 2 | 2017 | 22 | 0.300 |
Why?
|
| Intestinal Mucosa | 4 | 2016 | 797 | 0.300 |
Why?
|
| Peptide Hormones | 1 | 2006 | 29 | 0.290 |
Why?
|
| Growth Hormone-Releasing Hormone | 2 | 2003 | 7 | 0.280 |
Why?
|
| Head and Neck Neoplasms | 4 | 2019 | 1052 | 0.250 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2019 | 2601 | 0.240 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2019 | 1204 | 0.240 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2002 | 12 | 0.220 |
Why?
|
| Dwarfism | 1 | 2002 | 16 | 0.220 |
Why?
|
| Neoplasms | 2 | 2014 | 2898 | 0.220 |
Why?
|
| Glucagon | 1 | 2002 | 111 | 0.210 |
Why?
|
| Positron-Emission Tomography | 3 | 2023 | 329 | 0.210 |
Why?
|
| Radiotherapy | 2 | 2018 | 328 | 0.180 |
Why?
|
| Papillomaviridae | 2 | 2018 | 153 | 0.180 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2019 | 64 | 0.170 |
Why?
|
| Radiometry | 3 | 2023 | 53 | 0.170 |
Why?
|
| Tumor Burden | 2 | 2017 | 289 | 0.170 |
Why?
|
| Peptides | 1 | 2002 | 639 | 0.170 |
Why?
|
| Islets of Langerhans | 1 | 2002 | 544 | 0.170 |
Why?
|
| Photons | 1 | 2018 | 46 | 0.170 |
Why?
|
| Mice, Knockout | 4 | 2016 | 1924 | 0.150 |
Why?
|
| Four-Dimensional Computed Tomography | 1 | 2017 | 18 | 0.150 |
Why?
|
| Relative Biological Effectiveness | 1 | 2016 | 13 | 0.150 |
Why?
|
| Humans | 16 | 2023 | 86645 | 0.150 |
Why?
|
| Insulin | 1 | 2002 | 1160 | 0.150 |
Why?
|
| Uncertainty | 1 | 2017 | 71 | 0.150 |
Why?
|
| Esophagus | 1 | 2017 | 102 | 0.140 |
Why?
|
| Papillomavirus Infections | 1 | 2019 | 239 | 0.140 |
Why?
|
| Colon | 2 | 2010 | 496 | 0.140 |
Why?
|
| Hodgkin Disease | 1 | 2017 | 177 | 0.140 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2016 | 100 | 0.140 |
Why?
|
| Simulation Training | 1 | 2017 | 88 | 0.130 |
Why?
|
| Respiration | 1 | 2017 | 262 | 0.130 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2016 | 118 | 0.130 |
Why?
|
| Tumor Cells, Cultured | 1 | 2016 | 1041 | 0.130 |
Why?
|
| Radiotherapy, High-Energy | 1 | 2014 | 49 | 0.130 |
Why?
|
| Carcinoma, Acinar Cell | 1 | 2014 | 11 | 0.130 |
Why?
|
| Autophagy | 1 | 2016 | 149 | 0.130 |
Why?
|
| Parotid Neoplasms | 1 | 2014 | 17 | 0.130 |
Why?
|
| Stress, Physiological | 1 | 2016 | 227 | 0.120 |
Why?
|
| Proprotein Convertases | 3 | 2003 | 26 | 0.120 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2014 | 48 | 0.120 |
Why?
|
| Lung Neoplasms | 2 | 2017 | 2262 | 0.120 |
Why?
|
| Consensus | 1 | 2016 | 335 | 0.120 |
Why?
|
| Radiotherapy, Image-Guided | 1 | 2014 | 56 | 0.120 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 2705 | 0.110 |
Why?
|
| Quality Improvement | 1 | 2017 | 428 | 0.110 |
Why?
|
| Mice | 7 | 2016 | 11352 | 0.100 |
Why?
|
| Glioma | 1 | 2014 | 285 | 0.100 |
Why?
|
| Cysteine Endopeptidases | 1 | 2011 | 87 | 0.100 |
Why?
|
| Synchrotrons | 2 | 2022 | 28 | 0.100 |
Why?
|
| Lung | 1 | 2017 | 1170 | 0.100 |
Why?
|
| Microdissection | 1 | 2010 | 18 | 0.100 |
Why?
|
| Tight Junctions | 1 | 2011 | 149 | 0.090 |
Why?
|
| Metagenome | 1 | 2010 | 102 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2011 | 379 | 0.090 |
Why?
|
| 3' Untranslated Regions | 1 | 2009 | 92 | 0.080 |
Why?
|
| Brain Neoplasms | 1 | 2014 | 763 | 0.080 |
Why?
|
| Biodiversity | 1 | 2010 | 197 | 0.080 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2009 | 113 | 0.080 |
Why?
|
| Animals | 8 | 2016 | 26582 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 1169 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 696 | 0.070 |
Why?
|
| Protein Biosynthesis | 1 | 2009 | 378 | 0.070 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 1075 | 0.070 |
Why?
|
| Ghrelin | 1 | 2006 | 29 | 0.070 |
Why?
|
| Gastric Mucosa | 1 | 2006 | 66 | 0.070 |
Why?
|
| Cell Line | 4 | 2016 | 2468 | 0.070 |
Why?
|
| Neurosecretory Systems | 2 | 2003 | 35 | 0.070 |
Why?
|
| DNA Repair | 2 | 2019 | 356 | 0.070 |
Why?
|
| Colitis | 1 | 2009 | 239 | 0.070 |
Why?
|
| Stomach | 1 | 2006 | 108 | 0.070 |
Why?
|
| Molecular Sequence Data | 2 | 2010 | 3030 | 0.070 |
Why?
|
| Time Factors | 2 | 2011 | 5210 | 0.070 |
Why?
|
| Amino Acid Sequence | 2 | 2006 | 2062 | 0.070 |
Why?
|
| Scattering, Radiation | 2 | 2016 | 114 | 0.070 |
Why?
|
| Furin | 1 | 2003 | 11 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2009 | 3092 | 0.060 |
Why?
|
| Polymethyl Methacrylate | 1 | 2023 | 12 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 2426 | 0.060 |
Why?
|
| Child | 1 | 2014 | 6928 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2014 | 1721 | 0.060 |
Why?
|
| Proglucagon | 1 | 2002 | 5 | 0.060 |
Why?
|
| Corticosterone | 1 | 2002 | 35 | 0.050 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2002 | 48 | 0.050 |
Why?
|
| Gene Targeting | 1 | 2002 | 72 | 0.050 |
Why?
|
| Growth Hormone | 1 | 2002 | 97 | 0.050 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2002 | 131 | 0.050 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2002 | 114 | 0.050 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2018 | 1076 | 0.050 |
Why?
|
| Quality Control | 1 | 2019 | 117 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2002 | 503 | 0.040 |
Why?
|
| Male | 3 | 2017 | 40967 | 0.040 |
Why?
|
| Necrosis | 1 | 2018 | 204 | 0.040 |
Why?
|
| Mitosis | 1 | 2018 | 153 | 0.040 |
Why?
|
| Cellular Senescence | 1 | 2018 | 94 | 0.040 |
Why?
|
| Proteomics | 1 | 2019 | 212 | 0.040 |
Why?
|
| Gene Expression | 1 | 2002 | 1284 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2018 | 3241 | 0.040 |
Why?
|
| Bifidobacterium breve | 1 | 2016 | 2 | 0.040 |
Why?
|
| Autophagy-Related Protein 5 | 1 | 2016 | 11 | 0.040 |
Why?
|
| Autophagy-Related Protein 7 | 1 | 2016 | 12 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2011 | 1540 | 0.040 |
Why?
|
| Radiation Tolerance | 1 | 2016 | 168 | 0.030 |
Why?
|
| Organ Sparing Treatments | 1 | 2016 | 38 | 0.030 |
Why?
|
| Reference Values | 1 | 2016 | 674 | 0.030 |
Why?
|
| Adult | 1 | 2014 | 25648 | 0.030 |
Why?
|
| DNA Damage | 1 | 2016 | 366 | 0.030 |
Why?
|
| Radiation Injuries | 1 | 2016 | 155 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2014 | 90 | 0.030 |
Why?
|
| Cell Survival | 1 | 2016 | 969 | 0.030 |
Why?
|
| Equipment Design | 1 | 2014 | 406 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2017 | 8491 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2016 | 669 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 1939 | 0.030 |
Why?
|
| Apoptosis | 1 | 2018 | 1683 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2014 | 751 | 0.030 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2011 | 15 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2011 | 151 | 0.030 |
Why?
|
| DNA, Ribosomal | 1 | 2010 | 44 | 0.020 |
Why?
|
| Inflammation | 1 | 2016 | 920 | 0.020 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2010 | 36 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 1169 | 0.020 |
Why?
|
| Human Experimentation | 1 | 2010 | 39 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 1991 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2010 | 236 | 0.020 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2010 | 241 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2010 | 369 | 0.020 |
Why?
|
| Dextran Sulfate | 1 | 2009 | 68 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2009 | 268 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 683 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2009 | 504 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 1753 | 0.020 |
Why?
|
| Transfection | 1 | 2009 | 896 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2010 | 853 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2010 | 456 | 0.020 |
Why?
|
| Homeostasis | 1 | 2009 | 409 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2011 | 1208 | 0.020 |
Why?
|
| Phylogeny | 1 | 2010 | 1137 | 0.020 |
Why?
|
| Cytokines | 1 | 2009 | 776 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2003 | 93 | 0.010 |
Why?
|
| Female | 2 | 2017 | 44534 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2003 | 290 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 1801 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 2003 | 156 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 144 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 279 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2003 | 305 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 2232 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 646 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2003 | 339 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 7993 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2003 | 439 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2003 | 526 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 557 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 1014 | 0.010 |
Why?
|
| Aged | 1 | 2017 | 18415 | 0.010 |
Why?
|
| Binding Sites | 1 | 2003 | 1098 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2003 | 881 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2003 | 1286 | 0.010 |
Why?
|
| Middle Aged | 1 | 2017 | 25028 | 0.010 |
Why?
|
| Rats | 1 | 2003 | 3990 | 0.010 |
Why?
|
| Models, Biological | 1 | 2003 | 1749 | 0.010 |
Why?
|